Dementia Drugs Lecanemab and Donanemab Face Scrutiny Over Potential Brain Shrinking and Harmful Side…
The Medicines and Healthcare products Regulatory Agency (MHRA) is expected to make a decision on approval as early as next week. Approval…
Read More...
Read More...